Skip to main content

Table 2 rev alleles with rare Pro-74, Leu-104 and/or Pro-106 mutationsa

From: Persistence of attenuated HIV-1 rev alleles in an epidemiologically linked cohort of long-term survivors infected with nef-deleted virus

Clade B HIV-1 strain or Rev clone

Residue at position: (Clade B consensus residue; frequencyb)

Frequency of residue combinationb

Status of HIV-1 progressiond

GenBank accession no.

Reference

 

74 (Gln; 0.90)

104 (Val; 0.94)

106 (Ser; 0.97)

    

C64

Pro

Leu

Pro

unique

LTNP

EF634155

This report

D36

Pro

Leu

Pro

unique

LTS

EF634154

This report

MAc

Gln

Val

Ser

0.884

LTS

N/A

Iversen et al., [10]

C42

Pro

Val

Ser

0.049

N/A

AF538305

Unpublished

D31

Pro

Val

Ser

0.049

N/A

U43096

Kreutz et al., [48]

UKR1216

Pro

Val

Ser

0.049

N/A

AF193278

Liitsola et al., [49]

NY5CG

Gln

Leu

Ser

0.018

AIDS

M38431

Willey et al., [50]

89.6

Pro

Val

Ser

0.049

AIDS

U39362

Collman et al., [51]

WEAU160

Pro

Leu

Ser

0.006

N/A

U21135

Unpublished

1299_d22

His

Val

Pro

0.018

N/A

AY308761

Bernardin et al., [52]

1006_08

Pro

Val

Ser

0.049

Acute infection

AY331284

Bernardin et al., [53]

1058_08

Pro

Val

Ser

0.049

Acute infection

AY331294

Bernardin et al., [53]

PRB959_03

Gln

Val

Pro

0.018

Acute infection

AY331296

Bernardin et al., [53]

RU128005

Gln

Val

Pro

0.018

N/A

AY682547

Unpublished

98USHVTN3605c9

Pro

Val

Ser

0.049

N/A

AY560108

Unpublished

PCM013

Glu

Leu

Ser

0.018

N/A

AY561237

Unpublished

50333-03

Gln

Leu

Ser

0.018

LTS

U30750

Iversen et al., [10]

931395-04

Pro

Val

Ser

0.049

AIDS

U30775

Iversen et al., [10]

LA-09

Gln

Leu

Pro

0.006

AIDS

U30785

Iversen et al., [10]

  1. a; Sixteen of 164 Clade B HIV-1 rev sequences screened from the Los Alamos National Laboratory HIV Database and other published studies [10] contained Pro-74, Leu-104 and/or Pro-106 mutations. Underlined boldface indicates the presence of one or more of these rare amino acid changes.
  2. b; Amino acid frequency was calculated by dividing the number of sequences with the amino acid, or the particular amino acid combination, by the total number of sequences analyzed (n = 164).
  3. c; Patient MA, identified as a LTS with attenuated rev alleles in a previous study by Iversen et al., [10] was included for comparison.
  4. d; LTNP, long-term nonprogressor; LTS, long-term survivor; AIDS, acquired immune deficiency syndrome; N/A, not available.